The CF Foundation recently provided an update on the following research trial.
Inhaled Mannitol in Adults with Cystic Fibrosis
This is a phase 3 multi-center trial that will look at how well the drug mannitol works at a certain dose taken twice daily and how safe it is in adults with cystic fibrosis. Researchers aim to show that people taking mannitol have better lung function than people taking an alternative medication. If the trial is successful they will try to get FDA approval of the drug for public use.
- CFF Link: http://www.cff.org/Display/dsp_ClinicalResearchHTML.cfm?id=360&CTSubId=74
- ClinicalTrials.gov Link: http://www.clinicaltrials.gov/ct2/show/NCT02134353